YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

FDA gives green light to nasal spray alternative for allergic reactions

Posted online

The Food and Drug Administration has given the OK to the first nasal spray treatment for serious allergic reactions, such as anaphylaxis.

Neffy, a product from ARS Pharmaceuticals, is now the only needle-free alternative to EpiPens and other epinephrine injectors, according to Quartz.

A single-dose nasal spray, Neffy is administered into one nostril.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences